Status | Study |
Recruiting |
Study Name: A Phase I Study of Abatacept in the Treatment of Patients With Steroid Refractory Chronic Graft Versus Host Disease (cGVHD) Condition: Chronic Graft Versus Host Disease Date: 2013-09-27 Interventions: Drug: Abatacept The study will follow a standard 3+3 design with two escalating doses of abatacept to de |
Active, not recruiting |
Study Name: Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease Condition: Graft vs. Host Disease Date: 2012-10-22 Interventions: Drug: Ustekinumab One subcutan |
Recruiting |
Study Name: Mesenchymal Stromal Cells for Acute Graft Versus Host Disease Condition: Acute GVH Disease Date: 2012-04-26 Interventions: Biological: Mesenchymal stromal cell therapy One arm will be randomised to receive mesenchymal stromal c |
Completed |
Study Name: The Natural History of Graft-Versus-Host Disease in the Eyes Condition: Graft-Versus-Host Disease Date: 2011-06-08 |
Completed |
Study Name: Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD) Condition: Chronic Graft-versus-host Disease Date: 2010-07-12 Interventions: Drug: Rituximab Rituximab 375 mg/m2/dose x 4 weekly doses on days 1, 8, 15 and 22 and then at 3, 6, 9 an |
Terminated |
Study Name: Intra Arterial (IA) Steroids Infusion for Hepatic Acute Hepatic Graft Versus Host Disease (aGVHD) Condition: Acute Graft Versus Host Disease Date: 2010-06-09 Interventions: Drug: Methylprednisolone (Intra-arterial continuous infusion of corticosteroids) Sedation/anesthesia of |
Terminated |
Study Name: A Study of Rituximab Combined With Prednisone for the Initial Treatment of Chronic Graft Versus Host Disease (cGVHD) Condition: Graft Versus Host Disease Date: 2010-02-08 Interventions: Drug: Rituximab Rituximab 375 mg/m2 IV weekly X 4 doses + Prednisone 1 mg/kg/d |
Terminated |
Study Name: Alefacept for Prevention of Graft Versus Host Disease (GVHD) Condition: Graft Versus Host Disease Date: 2006-07-31 Interventions: Drug: Alefacept (AMEVIVE®) |
Completed |
Study Name: Compassionate Use of Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Gastrointestinal Tract Condition: Graft Versus Host Disease Date: 2003-03-06 Interventions: Drug: beclomethasone dipropionate |
Completed |
Study Name: Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease Condition: Graft Versus Host Disease Date: 2003-02-05 Interventions: Biological: Daclizumab Other N |